Skip to main content
logo
LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
45.33
-0.52 (-1.13%)
Aug 11, 2026, 4:00 PM EDT - Market closed

LB Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Cap
1,462563---
Market Cap Growth
-----
Enterprise Value
1,140271.52000
Last Close Price
45.3322.26---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
3.911.87---
P/TBV Ratio
3.060.59---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.160-1.12
Net Debt / Equity Ratio
-0.97-0.970.261.26-0.09
Net Debt / EBITDA Ratio
3.409.700.383.81-0.98
Net Debt / FCF Ratio
3.898.270.453.57-1.01
Quick Ratio
13.9139.673.4516.6145.64
Current Ratio
15.0841.443.5617.5145.82
Return on Equity (ROE)
-27.04%-15.70%-206.22%-63.14%66.37%
Return on Assets (ROA)
-28.20%-17.55%-163.73%-33.89%-13.07%
Return on Invested Capital (ROIC)
-723.44%-1198.24%--118.36%-13.36%
Return on Capital Employed (ROCE)
-29.56%-18.38%-189.35%-35.51%-13.36%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Buyback Yield / Dilution
-8821.45%-2145.81%-24.75%-24.27%-
Total Shareholder Return
-8821.45%-2145.81%-24.75%-24.27%-
SEC Filings: 10-K · 10-Q